Statement of Bernard Siegel on Stem Cell Court Case, Sherley v. Sebelius

WASHINGTON--(BUSINESS WIRE)-- The following statement may be attributed to Bernard Siegel, J.D., spokesperson for the Stem Cell Action Coalition and executive director of the Genetics Policy Institute (GPI):

“The Stem Cell Action Coalition, comprising 73 nonprofit organizations, applauds the decisive ruling in the case of Sherley v. Sebelius. With this ruling in favor of the government, a dark cloud has been lifted and NIH funding for embryonic stem cell research should accelerate. This ruling places the government on very solid legal footing moving forward. I am optimistic, when all is said in done, the pro-cures cause will prevail and the full promise of embryonic stem cells will be delivered."

“We are very grateful to Neal Goldfarb, of the law firm of Butzel Long Tighe Patton, PLLC in Washington, D.C., for his efforts in writing the brief on behalf of the Genetics Policy Institute, which presented arguments in the case in support of the government’s position.”

An initiative organized by GPI, the Stem Cell Action Coalition aims to foster public awareness about the promise of embryonic stem cell research and its translation into regenerative medicine, promote robust funding of basic research and translational medicine within ethically responsible and scientifically sound guidelines, and vigorously defend this research from unwarranted restrictions. In addition to covering the critical legal issues at the U.S. federal level, the Coalition places a special focus on challenges at the state level, and serves as a facilitator to coordinate advocacy among all stakeholders.

The Genetics Policy Institute (GPI) supports stem cell research to develop therapeutics and cures. It pursues its mission through producing the annual World Stem Cell Summit, publishing the World Stem Cell Report, honoring leadership through its annual Stem Cell Action Awards, organizing educational and public awareness initiatives, and fostering strategic collaborations.



CONTACT:

Genetics Policy Institute
Bernard Siegel, 305-801-4928

KEYWORDS:   United States  North America  District of Columbia

INDUSTRY KEYWORDS:   Seniors  Stem Cells  Women  Health  AIDS  Alternative Medicine  Cardiology  Clinical Trials  Dental  Fitness & Nutrition  Genetics  Hospitals  Infectious Diseases  Public Policy/Government  Medical Devices  Congressional News/Views  Law Enforcement/Emergency Services  Mental Health  Courts  Oncology  Optical  Pharmaceutical  Radiology  State/Local  Philanthropy  Professional Services  Baby/Maternity  Teens  Legal  Communications  Research  Other Science  Other Philanthropy  Other Communications  Diabetes  FDA  Consumer  Medical Supplies  Nursing  Science  Gay & Lesbian  Foundation  Fund Raising  General Health  Men  Managed Care  Physical Therapy

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.